Evidence map›Paper›PMID 25184567›Full record

ArticlePloS one2014

Search for microRNAs expressed by intracellular bacterial pathogens in infected mammalian cells.

Yuki Furuse, Ryan Finethy, Hector A Saka, Ana M Xet-Mull, Dana M Sisk, Kristen L Jurcic Smith, Sunhee Lee, Jörn Coers, Raphael H Valdivia, David M Tobin and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Environmental Plasticity of the RNA Content ofFrontiers in microbiology · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yuki FuruseDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Ryan FinethyDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Hector A SakaDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Ana M Xet-MullDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Dana M SiskDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Kristen L Jurcic SmithDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Sunhee LeeDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Jörn CoersDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Raphael H ValdiviaDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
David M TobinDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Bryan R CullenDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke University Hospital · USDuke Medical Center · US

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
ORGANIZATION AND FUNCTIONS OF CELLULAR STRUCTUREST32GM007184 · NIGMS · DUKE UNIVERSITY · PI JINKS-ROBERTSON, SUE · 1985 to 2019
$18.2M
Modulating Eicosanoids to Treat Tuberculosis: Personalized, Host-directed TherapyDP2OD008614 · OD · DUKE UNIVERSITY · PI TOBIN, DAVID M. · 2011 to 2011
$2.4M
Forward and Reverse Genetics in ChlamydiaR01AI100759 · NIAID · DUKE UNIVERSITY · PI VALDIVIA, RAPHAEL H · 2012 to 2016
$2.2M
NIAID NIH HHS P30 AI064518NIAID NIH HHS P30-AI064518NIAID NIH HHS R01 AI100759NIAID NIH HHS R01-AI100759NIGMS NIH HHS T32 GM007184NIH HHS 1DP2-OD008614-01NIH HHS DP2 OD008614
6 · The paper itself

Abstract

MicroRNAs are expressed by all multicellular organisms and play a critical role as post-transcriptional regulators of gene expression. Moreover, different microRNA species are known to influence the progression of a range of different diseases, including cancer and microbial infections. A number of different human viruses also encode microRNAs that can attenuate cellular innate immune responses and promote viral replication, and a fungal pathogen that infects plants has recently been shown to express microRNAs in infected cells that repress host cell immune responses and promote fungal pathogenesis. Here, we have used deep sequencing of total expressed small RNAs, as well as small RNAs associated with the cellular RNA-induced silencing complex RISC, to search for microRNAs that are potentially expressed by intracellular bacterial pathogens and translocated into infected animal cells. In the case of Legionella and Chlamydia and the two mycobacterial species M. smegmatis and M. tuberculosis, we failed to detect any bacterial small RNAs that had the characteristics expected for authentic microRNAs, although large numbers of small RNAs of bacterial origin could be recovered. However, a third mycobacterial species, M. marinum, did express an ∼ 23-nt small RNA that was bound by RISC and derived from an RNA stem-loop with the characteristics expected for a pre-microRNA. While intracellular expression of this candidate bacterial microRNA was too low to effectively repress target mRNA species in infected cultured cells in vitro, artificial overexpression of this potential bacterial pre-microRNA did result in the efficient repression of a target mRNA. This bacterial small RNA therefore represents the first candidate microRNA of bacterial origin.

Indexed as

High-Throughput Nucleotide SequencingCarboxypeptidasesChlamydiaGene Expression RegulationHost-Pathogen InteractionsHumansImmunity, InnateLegionellaMicroRNAsMycobacterium tuberculosisRNA, BacterialCarboxypeptidasesMicroRNAsRNA, BacterialSCPEP1 protein, human

Identifiers

PMID25184567
PMCPMC4153649
OpenAlexW1969816048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.